NanoViricides Inc Stock OTC Bulletin Board
Equities
US6300871042
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 21.2M 28.86M |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.89M | Net income 2025 * | -14M -19.06M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.05
x | P/E ratio 2025 * |
-2.01
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.68% |
Managers | Title | Age | Since |
---|---|---|---|
Anil Diwan
CEO | Chief Executive Officer | 66 | 05-03-31 |
Meeta Vyas
DFI | Director of Finance/CFO | 66 | 13-05-12 |
Jayant Tatake
CTO | Chief Tech/Sci/R&D Officer | - | 10-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Zucker
BRD | Director/Board Member | 62 | 20-11-12 |
Anil Diwan
CEO | Chief Executive Officer | 66 | 05-03-31 |
Director/Board Member | 73 | 20-02-06 |
1st Jan change | Capi. | |
---|---|---|
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |